The APAC Platelet Aggregation Devices Market was valued at USD 47.49 million in 2022, to grow at a CAGR of 26.3%, to reach USD 152.62 million by 2027 during the forecast period 2022 to 2027.
The increase in the rise of burden of chronic illnesses as well as the growing elderly population in this region with the issues like Heart issues, such as stroke and coronary heart disease, are becoming more common, resulting in the burden of cardiac mortality, which has fueled the expansion of the platelet aggregation devices market it is due to the continuous change in the lifestyle. Therefore, the platelet aggregation systems used to identify bleeding disorders are likely to increase demand as the prevalence of bleeding diseases rises.
An increase in the technical developments and advancements in the platelet aggregometer contribute to the growth of the platelet aggregation devices market. As it includes, the most effective approach for detecting platelet abnormalities is by the light transmission aggregometry.
Furthermore, light transmission aggregometry requires a large sample volume, and analytical variables influence the results. Also, aggregometry techniques have been developed and advanced due to these factors in traditional aggregometry and are now widely utilized in the market. Therefore, these advances have been proven to improve acceptance rates and aid market expansion and growth.
Platelet aggregation systems are in high demand in academic and pharmaceutical companies due to increased research studies, primarily to understand the mechanisms involved in platelet interaction with vascular surfaces and to evaluate and screen anti-thrombotic factors to identify new targets for antiplatelet drugs.
An increase in the average costs of the devices worldwide restricts the market growth. In addition, the lack of skilled individuals and defects in traditional aggregometry methods affect the market's growth and advances of platelet aggregation devices.
This research report on the Asia Pacific Platelet Aggregation Devices Market has been segmented and sub-segmented into the following categories.
By End User:
Geographically, the Asia Pacific market is predicted to hold a more significant share in the global market of platelet aggregation devices in the forecast period. Due to the increase in the incidences of chronic diseases in this region, India and China hold the largest population in the world with an increase in the elderly population as Japan has the most significant proportion of older people, which accounts for 33.1 percent of its people.
China platelet aggregation devices market has the most significant overall population with 11.9 percent of the elderly population. In comparison, the Indian platelet aggregation devices market has the second-largest population, with 6.1 percent of the elderly population. Therefore, due to the substantial rise in the number of individuals suffering from cardiovascular illnesses, these regions are expected to boost the usage of platelet aggregation devices to research platelet aggregation globally, driving the market over the projected period.
Technological advancements in the field of aggregation devices due to the rise in the trends of the platelet aggregation testing methods with the increasing adoption and market preference of automated systems among diagnostic laboratories, and the growing advantages offered by the point-of-care testing analyzer are driving the market growth for the platelet aggregation devices.
The Indian platelets aggregation devices market is expected to increase over the forecast period. Because chronic diseases are on the rise, healthcare infrastructure is improving. Therefore, government policies are supportive, and the market is growing.
Top Companies dominating the Asia Pacific Platelet Aggregation Devices Market are Accriva Diagnostics, Helena Laboratories Corporation, BioData Corporation, Haemonetics Corporation, Siemens AG, Sysmex Corporation, Sentinel CH. S.p.A., Tem Group and Aggredyne, Inc.,
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.4 Consumables and Accessories
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2.2 Clinical Applications
18.104.22.168 Cardiovascular Applications
22.214.171.124 Orthopedic Applications
126.96.36.199 Other Clinical Applications
5.2.3 Research Applications
5.2.4 Y-o-Y Growth Analysis, By Application
5.2.5 Market Attractiveness Analysis, By Application
5.2.6 Market Share Analysis, By Application
5.3.2 Standalone Hospitals
5.3.3 Diagnostic Laboratories
5.3.4 Research and Academic Institutes
5.3.5 Other End Users
5.3.6 Y-o-Y Growth Analysis, By End User
5.3.7 Market Attractiveness Analysis, By End User
5.3.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By End User
6.1.4 Market Attractiveness Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Product
126.96.36.199 By Application
188.8.131.52 By End User
6.1.5 Market Share Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Product
18.104.22.168 By Application
22.214.171.124 By End User
6.5 South Korea
6.7 Rest of Asia Pacific
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Helena Laboratories Corporation
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Haemonetics Corporation
8.3 Siemens AG
8.4 Sysmex Corporation
8.5 Accriva Diagnostics
8.6 Sentinel CH. S.p.A.
8.7 Bio/Data Corporation
8.8 Tem Group
8.9 Aggredyne, Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.